JP2022532075A5 - - Google Patents
Info
- Publication number
- JP2022532075A5 JP2022532075A5 JP2021565885A JP2021565885A JP2022532075A5 JP 2022532075 A5 JP2022532075 A5 JP 2022532075A5 JP 2021565885 A JP2021565885 A JP 2021565885A JP 2021565885 A JP2021565885 A JP 2021565885A JP 2022532075 A5 JP2022532075 A5 JP 2022532075A5
- Authority
- JP
- Japan
- Prior art keywords
- glycero
- approximately
- peg
- phosphocholine
- nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962845184P | 2019-05-08 | 2019-05-08 | |
| US62/845,184 | 2019-05-08 | ||
| PCT/US2020/032241 WO2020227690A1 (en) | 2019-05-08 | 2020-05-08 | Methods of using lipid nanoparticles for delivering modified rna encoding a vegf-a polypeptide and pharmaceutical compositions comprising the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022532075A JP2022532075A (ja) | 2022-07-13 |
| JP2022532075A5 true JP2022532075A5 (https=) | 2023-05-10 |
Family
ID=71069932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021565885A Withdrawn JP2022532075A (ja) | 2019-05-08 | 2020-05-08 | Ｖｅｇｆ－ａポリペプチドをコードする改変ｒｎａを送達するために脂質ナノ粒子を使用する方法、及びこの脂質ナノ粒子を含む医薬組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220226243A1 (https=) |
| EP (1) | EP3965745A1 (https=) |
| JP (1) | JP2022532075A (https=) |
| CN (1) | CN114173826A (https=) |
| WO (1) | WO2020227690A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114306279A (zh) * | 2021-12-30 | 2022-04-12 | 复旦大学 | 基于科罗索酸或其类似物的脂质纳米颗粒系统及其制备方法和应用 |
| CN114617980A (zh) * | 2022-03-09 | 2022-06-14 | 广州国家实验室 | 可电离脂质纳米颗粒及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3247398A4 (en) * | 2015-01-23 | 2018-09-26 | Moderna Therapeutics, Inc. | Lipid nanoparticle compositions |
| JP6948313B6 (ja) | 2015-09-17 | 2022-01-14 | モデルナティエックス インコーポレイテッド | 治療剤の細胞内送達のための化合物および組成物 |
| US11458106B2 (en) * | 2016-05-09 | 2022-10-04 | Astrazeneca Ab | Lipid nanoparticles comprising lipophilic anti-inflammatory agents and methods of use thereof |
| CN116606861A (zh) * | 2016-06-07 | 2023-08-18 | 摩登纳特斯有限公司 | 编码vegf-a多肽的经修饰的rna、配制品和关于它们的用途 |
| SI3703658T1 (sl) * | 2017-10-31 | 2022-09-30 | Astrazeneca Ab | Lipidni nanodelci za dostavljanje spremenjene RNA, ki kodira polipeptid VEGF-A |
-
2020
- 2020-05-08 WO PCT/US2020/032241 patent/WO2020227690A1/en not_active Ceased
- 2020-05-08 US US17/609,258 patent/US20220226243A1/en not_active Abandoned
- 2020-05-08 JP JP2021565885A patent/JP2022532075A/ja not_active Withdrawn
- 2020-05-08 EP EP20731625.8A patent/EP3965745A1/en not_active Withdrawn
- 2020-05-08 CN CN202080046774.1A patent/CN114173826A/zh not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274230B2 (en) | Lipid nanoparticles for delivering modified rna encoding a vegf-a polypeptide | |
| JP2021508434A5 (https=) | ||
| JP5355890B2 (ja) | グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物 | |
| TW202011941A (zh) | 用於治療肺部疾病的可吸入的緩釋組成物 | |
| CN107260679B (zh) | 用以减少眼用类固醇的并发症的药物组合物 | |
| US20170281541A1 (en) | Liposome-based mucus-penetrating particles for mucosal delivery | |
| CN118766874B (zh) | 一种吸入式制剂、迭代优化流程及其应用 | |
| JP2022532075A5 (https=) | ||
| WO2013176223A1 (ja) | 炎症性疾患治療用医薬組成物 | |
| WO2019082139A1 (en) | LIPOSOMAL FINGOLIMOD HYDROCHLORIDE INJECTION | |
| US10124015B2 (en) | Surfactant composition | |
| US20250177483A1 (en) | Transmembrane stem cell factor (tm-scf) lipid nanocarriers and methods of use thereof | |
| EP3496704B1 (en) | Liposomal composition containing mild acidic active agent | |
| JP2025506429A5 (https=) | ||
| US12514820B2 (en) | Pharmaceutical composition of intra-articular corticosteroid for pain control | |
| Pylypenko | “QUALITY BY DESIGN” IN LIPOSOMAL DRUGS CREATION | |
| TW202519194A (zh) | 用於疼痛控制之關節內皮質類固醇的微脂體組成物 | |
| NZ820531B2 (en) | Long-acting spleen-targeting cationic lipid compound comprising benzene ring structure, composition comprising same, and use thereof | |
| NZ820531A (en) | Long-acting spleen-targeting cationic lipid compound comprising benzene ring structure, composition comprising same, and use thereof | |
| KR20250172196A (ko) | 폐 계면활성제 및 항섬유화제를 포함하는 폐섬유증의 예방 또는 치료용 조성물 및 이의 제조방법 | |
| TW202415382A (zh) | 脂質體藥物組合物及其製備方法和用途 | |
| HK40043569B (zh) | 用於治疗肺部疾病的可吸入脂质体缓释组合物 |